Table 1.

Corrected disclosures (corrections are bolded)

AuthorOriginal DisclosuresCorrected Disclosures
Michel FischbachM.F. discloses consultancy and honoraria for Fresenius Medical Care.M.F. reports personal fees from Fresenius Medical Care, and other funding from Roche, outside the submitted work.
Sylvie C. Meyer ReignerS.C.M.R. and Z.M. are employees of F. Hoffmann-La Roche Ltd.S.C.M.R. and Z.M. are employees of F. Hoffmann-La Roche Ltd.
Zoe MorganS.C.M.R. and Z.M. are employees of F. Hoffmann-La Roche Ltd.S.C.M.R. and Z.M. are employees of F. Hoffmann-La Roche Ltd.
Franz SchaeferF.S. discloses consultancy for F. Hoffmann-la Roche Ltd., Bayer, Amgen, AbbVie, Alexion, and Otsuka; research funding from Fresenius Medical Care; honoraria from Alexion; and scientific advisory board activities for Alexion and Otsuka.F.S. discloses consultancy for F. Hoffmann-la Roche Ltd., Bayer, Amgen, AbbVie, Alexion, and Otsuka; research funding from Fresenius Medical Care; honoraria from Alexion; and scientific advisory board activities for Alexion and Otsuka.
Elke WühlE.W. has no conflicts to disclose.E.W. reports patient fees from Roche, during the conduct of the study.